Change in Quality of Life and Its Predictors in Heroin Users Receiving Methadone Maintenance Treatment in Taiwan: An 18-Month Follow-Up Study

REFERENCES

• Maremmani I, Pani PP, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat 2007; 33(1):91–98.
   PubMed Web of Science ®Google Scholar
• Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, Gebo KA. Health-related quality of life in HIV-infected patients: The role of substance use. AIDS Patient Care STDS 2008; 22(11):859–867.
   PubMed Web of Science ®Google Scholar
• Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martin-Santos R, Torrens M. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse 2008; 43(5):612–632.
   PubMed Web of Science ®Google Scholar
• Eklund C, Melin L, Hiltunen A, Borg S. Detoxification from methadone maintenance treatment in Sweden: Long-term outcome and effects on quality of life and life situation. Int J Addict 1994; 29(5):627–645.
   PubMed Web of Science ®Google Scholar
• Deng CF, Ma X, Zhou H, Liu QL, Yang Y, Song Z, Wu F. Quality of life of heroin dependent patients with methadone maintenance therapy. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40(3):539–543.
   PubMedGoogle Scholar
• Skevington SM, Lotfy M, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004; 13(2):299–310.
   PubMed Web of Science ®Google Scholar
• Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 2002; 101(5):342–351.
   PubMed Web of Science ®Google Scholar
• Chien CP, Cheng TA. Depression in Taiwan: Epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi 1985; 87(5):335–338.
   PubMedGoogle Scholar
• Chau TT, Hsiao TM, Huang CT, Liu HW. A preliminary study of family APGAR index in the Chinese. Gaoxiong Yi Xue Ke Xue Za Zhi 1991; 7(1):27–31.
   PubMedGoogle Scholar
• Smilkstein G. The family APGAR: A proposal for a family function test and its use by physicians. J Fam Pract 1978; 6(6):1231–1239.
   PubMed Web of Science ®Google Scholar
• Chen VC, Chen H, Lin TY, Chou HH, Lai TJ, Ferri CP, Gossop M. Severity of heroin dependence in Taiwan: Reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS). Addict Behav 2008; 33(12):1590–1593.
   PubMed Web of Science ®Google Scholar
• Yen CF, Yang YH, Ko CH, Yen JY. Substance initiation sequences among Taiwanese adolescents using methamphetamine. Psychiatry Clin Neurosci 2005; 59(6):683–689.
   PubMed Web of Science ®Google Scholar
• Apodaca TR, Longabaugh R. Mechanisms of change in motivational interviewing: A review and preliminary evaluation of the evidence. Addiction 2009; 104(5):705–715.
   PubMed Web of Science ®Google Scholar
• Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003; 3:CD002208.
   PubMedGoogle Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3:CD002209.
   PubMed Web of Science ®Google Scholar
• Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008; 2:CD004145.
   PubMed Web of Science ®Google Scholar
• Gelkopf M, Weizman T, Melamed Y, Adelson M, Bleich A. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Isr J Psychiatry Relat Sci 2006; 43(2):126–136.
   PubMed Web of Science ®Google Scholar
• Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: Psychosocial and pharmacological variables. J Subst Abuse Treat 2003; 25(1):1–8.
   PubMed Web of Science ®Google Scholar
• Schafer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment. Psychopathology 2010; 43(2):88–95.
   PubMed Web of Science ®Google Scholar
• Strasser J, Wiesbeck GA, Meier N, Stohler R, Dursteler-Macfarland KM. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients. J Clin Psychopharmacol 2010; 30(4):450–454.
   PubMed Web of Science ®Google Scholar
• O’Keefe EA, Wood R. Quality of life in HIV infection. Scand J Gastroenterol Suppl 1996; 221:30–32.
   PubMedGoogle Scholar
• Preau M, Bouhnik AD, Spire B, Leport C, Saves M, Picard O, Aproco-Copilote E. Health related quality of life and lipodystrophy syndrome among HIV-infected patients. L’Encephale 2006; 32(5 Pt 1):713–719.
   Google Scholar
• te Vaarwerk MJ, Gaal EA. Psychological distress and quality of life in drug-using and non-drug-using HIV-infected women. Eur J Public Health 2001; 11(1):109–115.
   PubMed Web of Science ®Google Scholar
• Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Brown BS. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse 2009; 35(1):38–42.
   PubMed Web of Science ®Google Scholar
• Jackson CT, Covell NH, Frisman LK, Essock SM. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. J Dual Diagn 2005; 1(1):49–63.
   Google Scholar